CVA Family Office’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.8K | Buy |
593
+80
| +16% | +$6.98K | 0.01% | 542 |
|
|
2025
Q1 | $35K | Sell |
513
-341
| -40% | -$23.3K | 0.01% | 579 |
|
|
2024
Q4 | $66.4K | Buy |
854
+684
| +402% | +$53.2K | 0.01% | 461 |
|
|
2024
Q3 | $11.4K | Sell |
170
-643
| -79% | -$43.1K | ﹤0.01% | 739 |
|
|
2024
Q2 | $92.2K | Buy |
813
+4
| +0.5% | +$454 | 0.02% | 367 |
|
|
2024
Q1 | $112K | Buy |
809
+4
| +0.5% | +$555 | 0.02% | 338 |
|
|
2023
Q4 | $99.9K | Buy |
+805
| New | +$99.9K | 0.02% | 334 |
|
|
2023
Q3 | – | Sell |
-890
| Closed | -$114K | – | 429 |
|
|
2023
Q2 | $114K | Hold |
890
| – | – | 0.02% | 289 |
|
|
2023
Q1 | $103K | Buy |
890
+30
| +3% | +$3.49K | 0.02% | 305 |
|
|
2022
Q4 | $97.4K | Buy |
860
+300
| +54% | +$34K | 0.02% | 296 |
|
|
2022
Q3 | $45K | Buy |
560
+230
| +70% | +$18.5K | 0.01% | 395 |
|
|
2022
Q2 | $25K | Sell |
330
-330
| -50% | -$25K | 0.01% | 499 |
|
|
2022
Q1 | $84K | Sell |
660
-160
| -20% | -$20.4K | 0.02% | 292 |
|
|
2021
Q4 | $110K | Buy |
+820
| New | +$110K | 0.03% | 237 |
|
|
2021
Q3 | – | Sell |
-816
| Closed | -$87K | – | 505 |
|
|
2021
Q2 | $87K | Buy |
816
+596
| +271% | +$63.5K | 0.02% | 258 |
|
|
2021
Q1 | $20K | Buy |
+220
| New | +$20K | 0.01% | 413 |
|